Skip to product information
1 of 1

APC Armenian hamster Anti-Human/Mouse/Rat CD278 Antibody (S-R578)

APC Armenian hamster Anti-Human/Mouse/Rat CD278 Antibody (S-R578)

Catalog Number: S0B5899 Application: FCM Reactivity: Human,Mouse,Rat Conjugation: APC Brand: Starter
Price:
Regular price $216.00 SGD
Regular price Sale price $216.00 SGD
Size:
For shipping services or bulk orders, you may request a quotation.
Secure checkout with
View full details

Product Details

Product Specification


Host Armenian hamster
Antigen CD278
Synonyms Inducible T-cell costimulator; Activation-inducible lymphocyte immunomediatory molecule; AILIM; ICOS
Location Cell membrane
Accession Q9Y6W8
Clone Number S-R578
Antibody Type Recombinant mAb
Isotype IgG
Application FCM
Reactivity Hu, Ms, Rt
Positive Sample ConA Treated C57BL/6 mouse splenocytes
Purification Protein G
Concentration 0.2 mg/ml
Conjugation APC
Physical Appearance Liquid
Storage Buffer

PBS, 1% BSA, 0.3% Proclin 300

Stability & Storage

12 months from date of receipt / reconstitution, 2 to 8 °C as supplied

Dilution


application dilution species
FCM 5μl per million cells in 100μl volume Ms

Background

CD278, also known as ICOS (Inducible T-cell Costimulator), is a type I transmembrane glycoprotein that belongs to the CD28 family of costimulatory immunoreceptors. It is expressed on the surface of activated T cells, including cytotoxic T cells, regulatory T cells (Tregs), and other types of T cells. Its ligand, ICOSL (B7-H2 or CD275), is found on antigen-presenting cells (APCs) such as dendritic cells and macrophages, as well as on B cells. ICOS functions as a homodimer and plays a crucial role in cell-cell signaling, immune responses, and the regulation of cell proliferation. The interaction between ICOS and ICOSL enhances T-cell activation, proliferation, and differentiation, and is essential for the development of follicular helper T cells (Tfh) and efficient B-cell antibody responses. ICOS has also been implicated in various disorders, including immunodeficiency and autoimmune diseases. In cancer immunotherapy, ICOS expression has been identified as a potential predictive biomarker for responses to checkpoint inhibitor treatments.

Picture

FC

Flow cytometric analysis of CD278 expression on ConA treated C57BL/6 mouse splenocytes. C57BL/6 mouse splenocytes treated 72h with ConA were stained with Brilliant Violet 421™ Rat Anti-Mouse CD3 Antibody and either APC Armenian hamster IgG Isotype Control (Left panel) or SDT APC Armenian hamster Anti-Human CD278 Antibody (Right panel) at 5 μl/test. Flow cytometry and data analysis were performed using BD FACSymphony™ A1 and FlowJo™ software.